Açık Akademik Arşiv Sistemi

Browsing by Author "Namdaroglu, Sinem"

Browsing by Author "Namdaroglu, Sinem"

Sort by: Order: Results:

  • Convalescent plasma therapy in patients with COVID-19 
    Altuntas, Fevzi; Ata, Naim; Yigenoglu, Tugce Nur; Basci, Semih; Dal, Mehmet Sinan; Korkmaz, Serdal; Namdaroglu, Sinem; Basturk, Abdulkadir; Hacibekiroglu, Tuba (PERGAMON-ELSEVIER SCIENCE LTD, 2021)
    Introduction: Passive antibody therapy has been used to immunize vulnerable people against infectious agents. In this study, we aim to investigate the efficacy of convalescent plasma (CP) in the treatment of severe and ...
  • Convalescent plasma therapy in patients withCOVID-19 
    Yigenoglu, Tugce Nur; Hacibekiroglu, Tuba; Berber, Ilhami; Dal, Mehmet Sinan; Basturk, Abdulkadir; Namdaroglu, Sinem; Korkmaz, Serdal; Ulas, Turgay; Dal, Tuba; Erkurt, Mehmet Ali; Turgut, Burhan; Altuntas, Fevzi (WILEY, 2020)
    There are currently no licensed vaccines or therapeutics for COVID-19. Anti-SARS CoV-2 antibody-containing plasmas, obtained from the recovered individuals who had confirmed COVID-19, have been started to be collected using ...
  • COVID-19 in hematopoietic cell transplant recipients 
    Altuntas, Fevzi; Ata, Naim; Yigenoglu, Tugce Nur; Basci, Semih; Dal, Mehmet Sinan; Korkmaz, Serdal; Namdaroglu, Sinem; Basturk, Abdulkadir; Hacibekiroglu, Tuba; Dogu, Mehmet Hilmi; Berber, Ilhami; Dal, Kursat; Erkurt, Mehmet Ali; Turgut, Burhan; Ulgu, Mustafa Mahir; Celik, Osman; Akunal, Abdullah; Birinci, Suayip (SPRINGERNATURE, 2021)
    In this study, we aim to report the outcome of COVID-19 in hematopoietic cell transplant (HCT) recipients. HCT recipients (n = 32) with hematological disease and hospitalized for COVID-19 were included in the study. A ...
  • Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors 
    Basci, Semih; Ata, Naim; Altuntas, Fevzi; Yigenoglu, Tugce Nur; Dal, Mehmet Sinan; Korkmaz, Serdal; Namdaroglu, Sinem; Basturk, Abdulkadir; Hacibekiroglu, Tuba; Dogu, Mehmet Hilmi; Berber, Ilhami; Dal, Kursat; Erkurt, Mehmet Ali; Turgut, Burhan; Caglayan, Murat; Ayvali, Mustafa Okan; Celik, Osman; Ulgu, Mustafa Mahir; Birinci, Suayip (SAGE PUBLICATIONS LTD, 2020)
    Introduction In this study, we aim to report the outcome of COVID-19 in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitor (TKI). Method The data of 16 laboratory-confirmed COVID-19 patients with ...
  • The outcome of COVID-19 in patients with hematological malignancy 
    Yigenoglu, Tugce N.; Ata, Naim; Altuntas, Fevzi; Basci, Semih; Dal, Mehmet Sinan; Korkmaz, Serdal; Namdaroglu, Sinem; Basturk, Abdulkadir; Hacibekiroglu, Tuba; Dogu, Mehmet H.; Dal, Kursat; Erkurt, Mehmet A.; Turgut, Burhan; Ulgu, Mustafa Mahir; Celik, Osman; Imrat, Ersan; Birinci, Suayip (WILEY, 2021)